Odinwell AB

Odinwell operates in the medical technology sector. The company specializes in the development of medical technology products for wound care. The company develops a platform for wound care with associated technological aids to analyze and facilitate the process of difficult-to-heal wounds. In addition to its main business, service and associated ancillary services are also offered. The business is conducted in Sweden with headquarters in Halmstad.

Quotes for Odinwell AB

Board

CEO

  • Marcus Andersson

Chairperson of the Board

  • Carl-Magnus Stensson

Board

  • Anders Husmark
  • Per Nellgård
  • Susanne Olauson
  • Ulrika Giers
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-06-30 2026-03-31 2025-12-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Number of months that the report spans Q2 3 Months Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months
Total revenue MSEK 0.05 0.11 0.00 0.00 0.00 0.00 0.00
Earnings before interest and tax MSEK -1.43 -1.18 -6.15 -1.18 -1.50 -1.70 -1.77
Profit before tax MSEK -1.43 -1.15 -5.85 -1.05 -1.40 -1.67 -1.73
Net profit MSEK -1.43 -1.15 -5.86 -1.06 -1.40 -1.67 -1.73
Earnings per share SEK -0.03 -0.02 -0.12 0.03 -0.04 -0.04 -0.07
Dividend per share SEK 0,00 0,00 0.00 0,00 0,00 0,00 0,00
Equity MSEK 36.47 34.50 35.65 35.65 35.23 36.63 32.22
Fixed assets MSEK 2.79 3.00 3.27 3.27 3.55 3.82 4.10
Intangible assets MSEK 30.35 29.70 28.65 28.65 27.51 26.48 25.51
Current assets MSEK 4.83 3.14 5.19 5.19 5.81 8.01 4.31
Total asset MSEK 37.96 35.84 37.11 37.11 36.87 38.31 33.92
Long term liabilities MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities MSEK 1.49 1.33 1.46 1.46 1.64 1.68 1.70
Number of shares SEK 55079358.00 51089351.00 48727286.00 48727286.00 39598290.00 39598290.00 23973300.00